Sustainability

By participating in the Low Carbon Society Action Plan of the Federation of Pharmaceutical Manufacturers’ Associations of Japan for the realization of a decarbonized society, the Hisamitsu Pharmaceutical Group reviewed its CO₂ emission reduction target in December 2021, and aims to reduce it by 46% compared to FY2013 by FY2030 (Scopes 1 and 2; target: Hisamitsu Pharmaceutical Group) and to achieve net zero emissions by FY2050. In order to ensure consistency with the position of industry associations in our Climate Change Strategy, we participate in government-sponsored seminars on climate change, including those organized by the Ministry of Economy, Trade and Industry, the Ministry of the Environment, and the Ministry of Health, Labor and Welfare, as well as those organized by industry associations, to gather information and share it with our employees. Furthermore, the contents are checked to ensure that they are in line with the Company’s position and approach, and in the case of any discrepancies, the environmental management division of the Company discusses them and then coordinates them through the Sustainability Promotion Committee, which is chaired by the Director in charge of sustainability promotion. Through this process, the Company aligns its Climate Change Strategy with activities carried out by industry associations.Our FY2024 performance was a 18.1% reduction compared to FY2013, and we will continue activities to steadily reduce our environmental impact toward the FY2030 target through further measures and efficient operations.

Social issues related to climate change is increasingly becoming important every year. The Hisamitsu Pharmaceutical Group assesses the environmental impact of the processes of R&D, production, and sales, and takes appropriate actions in all the areas of Scope 1, 2, and 3, including the reduction of such impact in our value chain, to help realize a rich global environment.For Scopes 1 and 2 to be managed within our Group, we develop a specific plan from a mid-term perspective and introduce measures for it, as well as reviewing the progress every fiscal year and exploring new risks and opportunities to update the plan on an ongoing basis.

Examples of specific activities in FY2024

In FY2024, at our domestic factories, we optimized energy consumption by segmenting air conditioning systems and managing temperature and humidity in each area. We also implemented measures such as converting some air conditioning equipment to steam-free systems, upgrading to high-efficiency packaged air conditioners, installing more solar panels, and switching to LED lighting. At our overseas factories, we also work to combat climate change by updating our boiler fuel from heavy oil to liquefied natural gas, which produces lower greenhouse gas emissions.Furthermore, with regard to fluorocarbons, which have the greatest environmental impact among greenhouse gases, we are compliant with the Act on the Rational Use and Proper Management of Fluorocarbons (abbreviated as the “Fluorocarbon Emissions Control Act”), and manage the relevant facilities by keeping ledgers, carrying out simple and regular inspections, creating records, and calculating the amount of leakage. When updating equipment, we promote the introduction of highly energy-efficient equipment that uses refrigerants with low global warming potential.

Although most of our products are transported by truck, we are working on a modal shift to reduce environmental impact on major routes with a high volume of transport, which will reduce the impact on the environment. In FY2024, we used ship and rail transportation, reducing CO₂ emissions by approximately 355 t compared to truck-only transportation. We will continue to strive to further reduce CO₂ emissions by actively incorporating ship and rail transportation while working to increase our loading efficiency and leveraging a joint delivery system.

We are working to reduce the environmental impact of corporate sales vehicles. For sales vehicles, we are gradually replacing our existing vehicles with hybrid models to reduce CO₂ emissions and conserve resources. As of September 2025, 100% of our company cars are now hybrids. Additionally, two EVs (electric vehicles) were introduced at our Kyushu Head Office starting in July 2022, and two more at the SAGA Global Research Center since its opening in March 2024.

Completed in February 2019 and certified as a ZEB (Zero Energy Building),* the Hisamitsu Pharmaceutical Museum (housed in the Kyushu Head Office) continued its energy-saving operation in FY2024 in accordance with the ZEB certification standards.
*Zero Energy Building (ZEB): Highest rank in the Building Energy-Efficiency Labeling System